Safety, tolerability, pharmacokinetics and relative bioavailability of BI 474121 in healthy males – a Phase I study

No abstract is available for this paper.

• Publication year

  2022

• Venue

  Neuroscience Applied

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers
  DOI 10.1016/j.nsa.2022.100272
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• No references are available for this paper.

• Effects of the phosphodiesterase 2 inhibitor BI 474121 on central nervous system cyclic guanosine monophosphate concentrations: Translational studies

  2024influential citation